Nephros Inc. (NASDAQ:NEPH) Sees Large Drop in Short Interest

Nephros Inc. (NASDAQ:NEPH) was the recipient of a large decrease in short interest in the month of February. As of February 27th, there was short interest totaling 4,205 shares, a decrease of 57.8% from the February 12th total of 9,959 shares. Based on an average trading volume of 46,029 shares, the short-interest ratio is currently 0.1 days. Currently, 0.0% of the shares of the company are sold short. Currently, 0.0% of the shares of the company are sold short. Based on an average trading volume of 46,029 shares, the short-interest ratio is currently 0.1 days.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings reaffirmed a “hold (c)” rating on shares of Nephros in a research report on Thursday, January 22nd. One equities research analyst has rated the stock with a Buy rating and one has issued a Hold rating to the company. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $6.00.

Institutional Investors Weigh In On Nephros

Several hedge funds and other institutional investors have recently added to or reduced their stakes in NEPH. Kestra Advisory Services LLC purchased a new position in shares of Nephros during the 4th quarter valued at about $29,000. Heron Bay Capital Management purchased a new stake in shares of Nephros in the fourth quarter worth about $66,000. Dimensional Fund Advisors LP acquired a new stake in Nephros during the third quarter worth about $64,000. Citadel Advisors LLC grew its holdings in Nephros by 39.2% during the third quarter. Citadel Advisors LLC now owns 16,545 shares of the company’s stock worth $78,000 after acquiring an additional 4,655 shares during the period. Finally, XTX Topco Ltd raised its position in Nephros by 48.5% during the fourth quarter. XTX Topco Ltd now owns 21,617 shares of the company’s stock valued at $105,000 after acquiring an additional 7,062 shares in the last quarter. 41.10% of the stock is owned by institutional investors and hedge funds.

Nephros Price Performance

NEPH traded down $0.30 during trading on Friday, reaching $3.50. 48,136 shares of the company’s stock were exchanged, compared to its average volume of 37,365. Nephros has a 1 year low of $1.49 and a 1 year high of $6.42. The company’s fifty day simple moving average is $4.23 and its 200-day simple moving average is $4.64. The stock has a market capitalization of $37.21 million, a P/E ratio of 31.82 and a beta of 1.42.

Nephros (NASDAQ:NEPH) last released its quarterly earnings data on Thursday, March 12th. The company reported $0.01 EPS for the quarter, meeting the consensus estimate of $0.01. The business had revenue of $4.73 million for the quarter, compared to the consensus estimate of $4.45 million. Nephros had a net margin of 6.35% and a return on equity of 12.40%.

About Nephros

Nephros, Inc is a development-stage company specializing in advanced water filtration and purification technologies for medical, laboratory, industrial and defense applications. The company’s core offering centers on proprietary hollow fiber ultrafilters designed to remove bacteria, viruses, endotoxins and particulates from water streams. These ultrafilters are used in hemodialysis systems to protect patient treatment, in pharmaceutical and laboratory environments to ensure water quality and in critical field-deployable units for military and emergency response.

The company’s product portfolio includes standalone filtration cartridges for point-of-use and point-of-entry installations in dialysis clinics and hospitals, as well as bench-top and portable water purification systems.